Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

256 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

NCT04307381

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Scottsdale, Arizona, United States
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Plymouth, Minnesota, United States
  • Ionis Investigative Site Cincinnati, Ohio, United States
View Trial Details
Completed

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

NCT05695248

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD. Scottsdale, Arizona, United States
  • Allergy & Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • Acuro Research, Inc. Little Rock, Arkansas, United States
View all 20 locations
View Trial Details
Completed

Evaluate the Neurological Effects of EryDex on Subjects With A-T

NCT06193200

Conditions
Ataxia, Ataxia Telangiectasia, Brain Diseases, +19 more
Locations
  • University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence Los Angeles, California, United States
  • The Johns Hopkins Hospital, Division of pediatric allergy and immunology Baltimore, Maryland, United States
  • Cincinnati Children's Hospital, Division of neurology Cincinnati, Ohio, United States
  • UT Health Houston, Department of pediatrics, division of child & adolescent neurology Houston, Texas, United States
View all 19 locations
View Trial Details
Completed

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

NCT01129544

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations
  • Mattel Children's Hospital - UCLA Los Angeles, California, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Cincinnati Children's Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

NCT05147181

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii im. Eugenii i Janusza Zeylandów/Szpital w Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Szpital Uniwersytecki nr 2 Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Szpital Uniwersytecki w Krakowie Krakow, Lesser Poland Voivodeship, Poland
  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu Wroclaw, Lower Silesian Voivodeship, Poland
View all 14 locations
View Trial Details
Completed

A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

NCT06346899

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujan, China
  • The First Affiliated Hospital ,Sun Yat-sen University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
View all 13 locations
View Trial Details

Related conditions